Celsion Corporation has launched a clinical trial, supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), to study the effectiveness of combining cancer drug ThermoDox with focused ultrasound to treat a range of tumours, including liver cancer. For the full story on Oxford Biomedical Research Centre website

Oxford mothers-to-be learn about gestational diabetes research

November 21, 2017

Oxford researchers have attended two events in Oxford to let pregnant women know how to have a healthy pregnancy and to ask them to get involved in giving their views on future research. For the full story on Oxford Biomedical Research Centre website

High blood pressure linked to common heart valve disorder

November 21, 2017

New research has, for the first time, established a strong link between high blood pressure and the most common heart valve disorder in high-income countries. The NIHR Oxford BRC-funded study by The George Institute for Global Health at the University of Oxford followed 5.5 million adults in the UK over 10 years and found that […]

Researchers thank Bloodwise fundraisers for funding critical leukaemia trial

November 21, 2017

Staff and patients at the Oxford Cancer Centre at the Churchill Hospital have thanked fundraisers for the Bloodwise charity who have raised enough money to fully fund a trial of a new leukaemia drug. The staff and patient Thelma, who has been on the trial, sent their appreciation in a video to Bloodwise after fundraisers, […]

World-first NHS trial for universal flu vaccine

November 21, 2017

The world’s first widespread human testing of a flu vaccine which NIHR Oxford BRC researchers hope will protect more over 65-year-olds against influenza has begun in the NHS. More than 10,000 people aged 65 and over will be asked to take part in a study supported by the National Institute for Health Research (NIHR) and […]

New way to detect heart damage caused by chemotherapy

October 04, 2017

Researchers at the University of Oxford have developed a new way to detect heart damage caused by chemotherapy. The high-tech scanning techniques were enabled by funding from the British Heart Foundation (BHF), and could reveal whether chemotherapy is damaging a person’s heart before any symptoms appear. For the full story on University of Oxford website